Cosmo and 3SBio Announce Signing of License Agreement for Winlevi® in China
Cosmo Pharmaceuticals N.V. (“Cosmo”) and 3SBio (1530.HK) today announced the signing of a License Agreement for Winlevi® (clascoterone) cream 1% in Mainland China, Taiwan, Hong Kong and Macao (“Greater China”).